PetVivo Reports Third Quarter 2022 Financial Results


PetVivo Holdings, Inc. (Nasdaq: PETV), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for the three and nine months ended December 31, 2021.

Highlights from the third quarter of 2022 and recent weeks include the following:

  • Generation of revenue from sales of Spryng
  • Increased emphasis on the sales and marketing of Spryng

Read more: